FDA Inspection
Excella GmbH & Co. KGExcella GmbH & Co. KG – FDA Inspection, Aug 10, 2018
Record Details
This FDA Inspection record concerns Excella GmbH & Co. KG, with an inspection on August 10, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Kumar G. Janoria (Issuing Officer)
- Yvins Dezan
View Company Profile
ID · 20fb405a-3bbe-4ad3-9b2e-30067a3b80ee
Inspection Facts
- Inspection number
- 1064238
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Excella GmbH & Co. KG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Excella GmbH & Co. KG
- FDA Inspection 1205496 - 2022-10-19
- FDA Inspection 1098271 - 2019-07-12
- FDA Inspection 1012240 - 2017-03-17
- FDA Inspection 933855 - 2015-05-29
- FDA Inspection 831974 - 2013-05-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.